About ICBiotec
ICBiotec is a Healthcare company based in Mount Horeb (United States) founded in 1998, and was acquired by eGenesis in May 2020. Provider of gene editing platform for the development of human-compatible organs, tissues and cells. The company was acqui-hired. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Technology Platforms. Its competitors include Beam Therapeutics, eGenesis and Korro Bio; 3 of its 3 listed competitors have raised funding.
Company details
ICBiotec was established in 1998 in Mount Horeb, United States. A gene editing platform is offered by the company within the biotechnology sector for advancing human-compatible organs, tissues, and cells. Operations are centered on genetic engineering tools and services that support regenerative medicine applications. Focus is placed on research and development activities conducted from the U.S. base, with relevance to therapeutic advancements in organ transplantation and tissue engineering.
- Headquarters Mount Horeb, United States
- Stage Acquired
- SectorsHealthcare
- Website icbiotec.com
- Acquired by eGenesis (May 2020)
Investors in ICBiotec
ICBiotec has secured backing from 1 investor. Prominent investors backing the company include eGenesis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Gene transplantation platform for humanizing pig cells is developed. | 2015 | egenesisbio.com | Cambridge, United States |
Investor details for ICBiotec
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ICBiotec
2 dated milestones of ICBiotec across 22 years, from founding to its latest funding, stage changes and deals.
- Founded ICBiotec is founded.
- Exit Acquired by eGenesis.
Competitors of ICBiotec
ICBiotec has 3 listed competitors in our database, 3 of them funded. They include Beam Therapeutics, eGenesis and Korro Bio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| beamtx.com | 2017 | Cambridge, United States | $222M | 340 | Developer of gene therapy using CRISPR base editing to treat diseases | |
| egenesisbio.com | 2015 | Cambridge, United States | $481.42M | 94 | Gene transplantation platform for humanizing pig cells is developed. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. |
Detailed competitors of ICBiotec
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as ICBiotec (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Icbiotec
Complete news archive for ICBiotec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ICBiotec
ICBiotec was founded in 1998.
ICBiotec is headquartered in Mount Horeb, United States. It is registered at Mount Horeb, Wisconsin, United States.
ICBiotec was established in 1998 in Mount Horeb, United States. A gene editing platform is offered by the company within the biotechnology sector for advancing human-compatible organs, tissues, and cells. Operations are centered on genetic engineering tools and services that support regenerative medicine applications. Focus is placed on research and development activities conducted from the U.S. base, with relevance to therapeutic advancements in organ transplantation and tissue engineering.
ICBiotec's top competitors include eGenesis, Korro Bio and Beam Therapeutics.
ICBiotec has 1 investor. Key investors include eGenesis.
Yes. ICBiotec was acquired by eGenesis in May 2020.